Raltegravir Switch for Toxicity or Adverse Events

Clinical trial NCT00958100 · COMPLETED

Trial details

NCT number: NCT00958100
Sponsor: Catholic University of the Sacred Heart
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HIV/AIDS Antiretroviral Therapy HIV Infections

Start date: 2009-08-01
Primary completion: 2010-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.